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CASE REPORT

FAMILIAL HOMOCYSTINURIA
Fareena Bilwani, Nadir Ali Syed: Mohammed Usman and Mohammed Khurshid

ABSTRACT
Two cases of siblings diagnosed as cases of familial homocystinuria are reported. Both the cases have classical
presentation of familial homocystinuria including history of dislocation of lens of the right eye. Brother had history of
psychomotor retardation while sister had a significant history of deep vein-thrombosis. Levels of plasma homocysteine
were elevated and urinary homocysteine was positive in both the cases.
KEY WORDS: Homocysteine. Familial homocystinuria. Cystathione-B synthase. N-methyf tetrahydrofofate reductase.

li\JTRODUCTIO\.
In the last tvvo decades, a growing amount of interest has been
focussed on hyperhomocystinemia as a risk factor of
thromboembolic disease. We present cases of tvvo siblings
diagnosed as cases of familial homocystinuria with
characteristic clinical presentation and biochemical results.!
This report highlights the classical presentation of this rare
cause of thrombophilia.

CASE RFPORT
CASE I: An 18-year-old female presented in hematologyoncology clinic with complains of pain and swelling in left calf
of tvvo weeks duration. Her birth and developmental history
was unremarkable. She was born by caesarean section without
any complications. There was no history of delayed
milestones. Her diet and appetite were normal.
Her past medical history was significant with tvvo catastrophic
events. One occurred in August 1994 with swelling and pain
in the right calf for 24 hours. Apart from routine laboratory
investigations done at that time, a doppler ultrasonographic
study revealed thrombosis in deep veins of the leg. This was
followed by amputation of the right leg. She also had history
of subluxation of the right eye lens in August 1995 followed by
surgical correction.
She was a product of consanguineous marriage. Both parents
and younger sister were healthy with no history of any
significant medical illness. Moreover, her elder brother had
significant medical history (described as case 2).
At the time of presentation her general examination showed
pallor while examination of limbs revealed swelling and
tenderness of left calf. Rest of the systemic examination was
unremarkable.
Her complete blood counts at the time of presentation
revealed anemia with hemoglobin of 8.3 gm I dl, while TLC,
differential count and platelet counts were normal. Peripheral
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blood film revealed anisocytosis, macrocytes, polychromasia,
target cells, poikilocytes and occasional right shift neutrophils.
The serum vitamin 8 12 levels and red cell folate levels were
normal. Hemoglobin electrophoresis was normal.
She was investigated for various causes of inherited
thrombophilia. She was found to have positive urinarv
homocysteine assay.l, while the plasma homocysteine leveb
were elevated i.e. 117.5 p.mol/L. Other laboratory
investigations were normal.
Based on the clinical presentation and laboratory data,
including normal vitamin 812 and red cell folate levels along
with a high level of plasma homocysteine she was diagnosed
to be a case of familial homocystinuria. She was then started
on a trial of folic acid, vitamin-86 (pyridoxine) and vitamin Bn
(methylcobolamin) supplementation.
CASF ~:The brother was 21-year-old who presented to the
neurology clinic with history of mental retardation since birth.
He also complained of pain and swelling of superficial call
veins since 4 months. He was born through a caesarean
section. His diet and appetite were also normaL His younger
sister was diagnosed to be a case of familial homocystinuria
(described as case 1).His past medical history included an
event of dislocation of lens of the right eye in 1987 followed by
surgical correction.
At the time of presentation, examination of limbs revealed
dilated but non-tender superficial veins of right leg. CNS
examination revealed psychomotor retardation. Rest of the
examination was unremarkable.
In view of his medical and family history, urinary
homocysteine was performed and found to be positive. The
plasma homocysteine levels were elevated i.e. 364.6 p.mol/L.
Doppler ultrasonography of the right leg showed no evidence
of deep vein thrombosis. His serum Br2 and red cell folate
levels were also found to be normal.
A diagnosis of familial homocystinuria was made and since
then he was kept on folic acid, vitamin B6 (pyridoxine) and
vitamin B12 (methylcobolamin) supplementation.
In both these cases activity of cystathione- fS synthase and
N-metl1yltetrahydrofolate reductase (MTHFR) could not be
done for further characterization of familial homocystinuri;;
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because of the unavailability of these tests. However, clinical
history and high levels of plasma homocysteine were
significant enough to make a diagnosis of familial
homocystinuria.

IJtSCUSS!O~

Homocysteine is a sulfur-containing amino acid formed
during the metabolism of methionine. Homocysteine is
metabolized by one of the two pathways.2 remethylation and
transulfuration. Remethylation is catalyzed by methionine
synthase, for which vitamin B12 is an essential cofactor.
N-methyltetra-hydrofolate is the donor in this reaction and
N-methyltetrahydrofolate reductase (MTHFR) act as a catalyst.
Under conditions in which excess methionine is present,
homocysteine enters transulfuration pathway, a reaction
catalyzed by vitamin B, dependent enzyme cystathione-B synthase.
Familial homocystinuria is an autosomal recessive disorder
and a number of defects have been identified) Familial
homocystinuria and homocystinemia has been classified into
three major categories.:> Type 1 or classic homocystinuria is
due to the deficiency of cystathione-B synthase - (CBS). It is
also the most frequent cause of hyperhomocystinemia. 4 In this
type diagnosis is usually made after 3 years of age when
sublaxation of lens occurs. Progressive mental retardation is
common along with psychiatric and behavioral disorders.
Affected individuals may also manifest skeletal abnormalities.
Thromboembolic episodes involving both large and small
vessels are common and may occur at any age. An elevation of
homocysteine is the diagnostic finding. The homozygous form
of this disease can be associated with plasma homocysteine
concentration of upto 400 Jlmol /L.2 Type 2 homocystinuria is
due to defects in methylcobalamin formation, which is a
cofactor for the enzyme methionine synthase. These patients
usually present with history of lethargy, poor feeding and
developmental delay in the first few months of life. Laboratory
studies reveal megaloblastic anemia, homocystinuria and
hypomethioninemia.3 Type 3 homocystinuria is due to the
deficiency of methylenetetrahydrofolate reductase. Complete
absence of the enzyme usually causes mental retardation,
microcephaly and spasticity. Laboratory findings reveal
moderate homocystinemia and homocystinuria. The
methionine concentration is low or normal.
Homocysteine (and its dimer homocysteine) ordinarily is
detectable only in trace amounts in plasma and urine.
Homocysteine may not be detectable in urine until total
plasma homocysteine levels exceed 150 ~-tmol/L. On this basis,
by measuring urinary homocysteine occasional patients
would be missed.S So when a strong suspicion is made of this
rare entity plasma homocysteine should be measured despite
negative urinary homocysteine.
Obligate heterozygote carriers have 22% to 47% cystathioneB- synthase activity in cultured fibroblasts or long-term
cultured lymphocytes. Prenatal diagnosis is available for
cystathione-£5-synthase deficiency using cultured chorionic
Villus cells or amniotic fluid cells to measure the activity of this
enzyme.6 Screening test for familial homocystinuria involves
the determination of levels of methionine. Newer methods
include direct methionine assay by tandem mass
spectrometry? Elevation in methionine level may be minimal
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during the first 3 days of life until there is adequate protein
intake. It may be preferable to screen for this disorder at 2 or 4
weeks of age.B
Various definitions have also been used to derive cut-off levels
for hyperhomocystinemia. The classification by Kang.9 is now
generally used, distinguishing moderate (15-30 J'mOI/L),
intermediate (>30 to 100p:mol/L) and severe hyperhomocystinemia (>100 p:mol /L) on the basis of concentration
measured during fasting.
Hyperhomocystinemia is now an established independent
risk factor for the vascular thrombosis. Various investigators
have reported a positive association between hyperhomocystinemia and venous thrombosis.IO However, in cases of
mild to moderate hyperhomocystinemia, controversy remains
regarding the association between homocysteine and vascular
occlusive disease.
A number of other factors influence homocysteine
metabolism, including several disease states and medications.
Elevated plasma homocysteine levels are seen in patients with
chronic renal failure, hypothyroidism, several types of
carcinomas and drugs including methotrexate, phenytoin and
theophylline etc. Elevated levels have also been reported in
patients with pernicious anemia.2
Uptil now, there is no consensus regarding the best method of
treatment. However, vitamin supplementation with folic acid,
pyridoxine and vitamin 812 is generally effecti\'e in reducing
homocysteine concentration. This, in turn, may help in
reducing the occurrence of thromboembolic event.
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